Clinical Trials
6 trialsNCT06725381 2026-05-08
A Phase 1 Study of SKB571 in Subjects With Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT07505771 2026-04-06
A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer
Immunome, Inc.
Phase EARLY_PHASE1 Recruiting
NCT02537418 2026-03-27
Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
Canadian Cancer Trials Group
Phase 1 Active not recruiting
NCT05006794 2026-01-07
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies
Gilead Sciences
Phase 1 Active not recruiting
NCT06600789 2025-11-03
A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies
Carrick Therapeutics Limited
Phase 1/2 Recruiting
NCT06933069 2025-09-11
Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 1 Recruiting